Stephen Wolniak knows the bad side of exposure on the Web, as you can read on page 10. After he was misidentified on an online message board, he was forced to change his number and consult lawyers. None of this, however, has kept him from his research and teaching, answering questions online about mitosis or, in his latest pursuit, a gallery of digital photos of plants and other species available at http://www.pbase.com/sigmasd9/steve_wolniak.Qiagen CEO Peer Schatz may have inherited his mitocho
Stephen Wolniak knows the bad side of exposure on the Web, as you can read on
Qiagen CEO Peer Schatz may have inherited his mitochondria from his mother, but he inherited his love of science from his father, a biochemist who co-discovered mitochondrial DNA in the 1960s. Now CEO of one of the largest biotechnology companies in Germany, Schatz writes on
Kelli Miller Stacy was on the way to a career in pharmacy when ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
